
Hematology-Oncologychimeric antigen receptor T cellsClonal hematopoiesis
Influence of Clonal Hematopoiesis and Neutropenia on CAR-T Therapy Outcomes in Hematologic Malignancies
By MedXY|Oct 6, 2026
CHIP and pre-treatment neutropenia do not significantly affect survival or main toxicities in CAR-T therapy for hematologic cancers but may predict specific inflammatory toxicities, indicating distinct risk profiles for patient management.